Xeris Biopharma Holdings XERS
NASDAQ XERS
$9.71 -0.27 (-2.67%)
As of: Sep 30, 2026 · 2:38 PM EDT

Xeris Biopharma Holdings (XERS) Enterprise Value (2020 - 2026)

Updated

Xeris Biopharma Holdings' Enterprise Value was $1.25 billion in Q2 2026, up 80.7% from $693.63 million a year earlier and up 40.9% from the prior quarter.

Analysis

Xeris Biopharma Holdings (XERS) Enterprise Value (2020 - 2026) Analysis & Trends

On a trailing twelve-month basis, Xeris Biopharma Holdings' Enterprise Value was $938.71 million through Jun 30, 2026, up 90.0% year-over-year; for FY2025, it came in at $1.19 billion, up 174.5% from FY2024.

  • Enterprise Value has now increased for three consecutive years, with a five-year compound annual growth rate of 73.5% (FY2020 to FY2025).
  • In earlier years, Enterprise Value was $434.94 million in FY2024 (+72.5%), $252.16 million in FY2023 (+325.4%), $59.28 million in FY2022 (-54.1%) and $129.12 million in FY2021 (+69.9%).
  • Quarterly Enterprise Value has moved between $59.28 million (Q4 2022) and $1.26 billion (Q3 2025) over five years.
  • Compared with a year earlier, Enterprise Value has increased for eight straight quarters, with growth averaging 135.0% over the last eight quarters.
  • The best year-over-year quarter for Enterprise Value over five years was Q4 2023 (growth of 325.4%); the worst was Q3 2021 (a decline of 70.3%).
  • Per Business Quant data, XERS's Enterprise Value in the three quarters before Q2 2026 was $889.09 million (Q1 2026), $1.19 billion (Q4 2025) and $1.26 billion (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn
10 Xeris Biopharma Holdings 1.73 Bn 1.30 Bn 79.59 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.25 Bn
Mar 31, 2026 889.09 Mn
Dec 31, 2025 1.19 Bn
Sep 30, 2025 1.26 Bn
Jun 30, 2025 693.63 Mn
Mar 31, 2025 798.08 Mn
Dec 31, 2024 434.94 Mn
Sep 30, 2024 355.26 Mn
Jun 30, 2024 257.54 Mn
Mar 31, 2024 240.22 Mn
Dec 31, 2023 252.16 Mn
Sep 30, 2023 190.83 Mn
Jun 30, 2023 280.92 Mn
Mar 31, 2023 128.68 Mn
Dec 31, 2022 59.28 Mn
Sep 30, 2022 118.67 Mn
Jun 30, 2022 97.82 Mn
Mar 31, 2022 214.81 Mn
Dec 31, 2021 129.12 Mn
Sep 30, 2021 69.94 Mn
API Access

Xeris Biopharma Holdings Enterprise Value API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=enterprise-value&ticker=XERS&period=max&api_key=YOUR_API_KEY